NCT04160936View on ClinicalTrials.gov

The Efficacy of Peritubal Analgesic Infiltration in Postoperative Pain Following Percutaneous Nephrolithotomy

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 10, 2018

Primary Completion Date

September 12, 2020

Study Completion Date

September 12, 2020

Conditions
Renal Stone
Interventions
DRUG

Marcaine Injectable Product

Following PCNL under general anesthesia, patients will receive 0.25% Bupivacaine ( Marcaine) local anesthetic infiltration

Trial Locations (1)

11942

Saddam Al Demour, Amman

All Listed Sponsors
lead

Saddam Al Demour

OTHER

NCT04160936 - The Efficacy of Peritubal Analgesic Infiltration in Postoperative Pain Following Percutaneous Nephrolithotomy | Biotech Hunter | Biotech Hunter